Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity
- 1 April 2008
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 48 (4), 464-474
- https://doi.org/10.1177/0091270008314254
Abstract
The clearance of racemic bupropion, metabolized selectively by CYP2B6 in vitro, has been used clinically to phenotype CYP2B6 activity, polymorphisms, and drug interactions but has known limitations. Bupropion hydroxylation by CYP2B6 is stereoselective. This investigation assessed the stereoselectivity of bupropion pharmacokinetics and the influence of CYP2B6 induction. Ten healthy volunteers received immediate-release bupropion before and after 7 days of rifampin. Plasma and urine bupropion and hydroxybupropion were analyzed using a stereoselective assay. Plasma area under the curve (AUC0-∞) and maximum concentrations were 3-fold greater for R- than S-bupropion. Bupropion apparent oral clearance was 3- and 2-fold greater for S- than R- and R,S-bupropion, respectively Hydroxybupropion plasma AUC0-∞ and elimination half-life were significantly less for (S,S)- than (R,R)- and the racemate. (S,S)-hydroxybupropion was formation rate limited, whereas (R,R)-hydroxybupropion and the racemate were elimination rate limited. Rifampin doubled both R- and S-bupropion clearance and caused 4-fold increases in both (R,R)- and (S,S)-hydroxybupropion formation clearances. Increases in the plasma hydroxybupropion/bupropion AUC0-∞ ratio were greater for (S,S)- than (R,R)-hydroxybupropion. Simplified plasma and urine metrics of stereoselective bupropion metabolism and clearance were identified. Because metabolite formation clearance is the best in vivo metric of enzyme activity and due, therefore, to faster S-bupropion elimination and formation rate-limited (S,S)-hydroxybupropion kinetics, stereoselective S-bupropion hydroxylation and (S,S)-hydroxybupropion formation clearance may be a useful and improved phenotypic probe for CYP2B6.Keywords
This publication has 38 references indexed in Scilit:
- Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MSJournal of Chromatography B, 2007
- Identification of bupropion urinary metabolites by liquid chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2007
- Enantiomeric Metabolic Interactions and Stereoselective Human Methadone MetabolismThe Journal of pharmacology and experimental therapeutics, 2007
- Bupropion for major depressive disorder: Pharmacokinetic and formulation considerationsClinical Therapeutics, 2005
- HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATIONDrug Metabolism and Disposition, 2004
- SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRODrug Metabolism and Disposition, 2004
- Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicinJournal of Pharmacy and Pharmacology, 2003
- Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking CessationDrugs, 2002
- Determination of drug-metabolizing enzyme activity in vivo : pharmacokinetic and statistical issuesXenobiotica, 1998
- Disposition of Bupropion in Healthy Volunteers andJournal of Clinical Psychopharmacology, 1990